I hope it’s for at least $316 million... “Amar
Post# of 30027
(Total Views: 403)
Posted On: 11/28/2018 9:25:04 AM
I hope it’s for at least $316 million... “Amarantus recently received an independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million.”
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼